Stock listing
OTC:BLPH Bellerophon Therapeutics Inc Stock
Follow Bellerophon Therapeutics Inc into a list and get an email when it puts out news.
Delisted OTC:BLPH no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- OTC:BLPH
- Asset type
- Stock
- Exchange
- OTC
- Currency
- USD
Bellerophon Therapeutics Inc on 6ix
- Decks
- 9 decks · latest Jun 5, 2023
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Technical Presentation (June 2023) | Technical | 9 slides | Jun 5, 2023 |
| Investor Presentation (January 2022) | Investor deck | 25 slides | Jan 5, 2022 |
| Investor Presentation (January 2021) | Investor deck | 32 slides | Jan 11, 2021 |
| Corporate Update (March 2020) | Corporate update | 16 slides | Mar 31, 2020 |
| Technical Presentation (December 2019) | Technical | 10 slides | Dec 17, 2019 |
| Investor Presentation (January 2019) | Investor deck | 29 slides | Jan 7, 2019 |
| Investor Presentation (October 2018) | Investor deck | 30 slides | Oct 16, 2018 |
| Investor Presentation (September 2018) | Investor deck | 30 slides | Sep 5, 2018 |
| Technical Presentation (September 2015) | Technical | 18 slides | Sep 25, 2015 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Daniel Tassé Other companies: DBV Technologies SA (Chief Executive Officer · Since at least Jan 1, 2021); Regenxbio Inc. (Independent Board Member · Since at least Aug 15, 2016); Mallinckrodt Inc (Interim Pres-Hospital Business · May 1, 2015 – May 1, 2015 · Past) | Director · Feb 13, 2015 – Jun 21, 2018 · Past |
| Jonathan M Peacock Other companies: Avantor, Inc. (Director · May 16, 2019 – May 8, 2025 · Past); Kite Pharma Inc (Director · Jun 19, 2014 – Oct 3, 2017 · Past); Amgen Inc. (EVP & CFO · Apr 25, 2013 – Oct 28, 2013 · Past) | Director · Feb 13, 2015 – Mar 31, 2021 · Past |
| Theodore T Wang Other companies: MariaDB plc (Director · Dec 16, 2022 – Jun 29, 2023 · Past); Angel Pond Holdings Corp (Chief Executive Officer, Director · May 6, 2021 – Dec 16, 2022 · Past); ChronoScale Corporation (Director · Nov 10, 2020 – Nov 10, 2020 · Past) | Director · Apr 26, 2021 – Jun 7, 2023 · Past |
| Andre V Moura Other companies: Avantor, Inc. (Director · May 16, 2019 – May 16, 2019 · Past) | Director · Apr 28, 2016 – Sep 10, 2020 · Past |
| Naseem Amin Other companies: Avadel Pharmaceuticals PLC (Director · Since at least May 17, 2024) | Director · Jun 29, 2015 – Jun 7, 2023 · Past |
| Amit Agrawal | Chief Operating Officer · Jul 8, 2015 – Jul 8, 2015 · Past |
| Amy Edmonds | VP Clinical Operations & Admin · May 22, 2019 – Sep 26, 2019 · Past |
| Deborah Quinn | Chief Medical Officer · Oct 21, 2015 – Jun 12, 2018 · Past |
| Fabian Tenenbaum | Chief Executive Officer, Director · Feb 29, 2016 – Nov 15, 2019 · Past |
| Martin Dekker | See Remarks · Jan 19, 2016 – Jun 7, 2023 · Past |
All 16 people
| Person | Seat |
|---|---|
| Matthew Bennett | Director · Mar 22, 2018 – Sep 10, 2020 · Past |
| Nicholas Laccona | FINANCIAL OFFICER, (PFO & PAO) · Sep 30, 2021 – Feb 10, 2023 · Past |
| Parag Suresh Shah | VP of Business Operations · Apr 6, 2016 – Jun 7, 2023 · Past |
| Peter Fernandes | See Remarks · May 18, 2015 – Jun 7, 2023 · Past |
| Scott P Bruder | Director · Feb 10, 2023 – Jun 7, 2023 · Past |
| Wassim FARES | Chief Medical Officer · Sep 10, 2020 – Sep 10, 2020 · Past |
Log in to ask 6ix AI your own questions about Bellerophon Therapeutics Inc.